Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 49 citing Strowig: Improved glycemic control without weight gain using triple therapy in type 2 diabetes. (0.08 sec) 

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for …

- cardiobarbanza.com [PDF] 
DM Nathan, JB Buse, MB Davidson, E … - Diabetologia, 2009 - Springer
Page 1. CONSENSUS STATEMENT UPDATE Medical management of hyperglycaemia in type
2 diabetes mellitus: a consensus algorithm for the initiation ...
Cited by 1054 - Related articles - BL Direct - All 92 versions

Gateways to clinical trials


M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com
Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha.
Cited by 148 - Related articles - All 9 versions

[PDF] The obesity pandemic: where have we been and where are we going?


J Roth, X Qiang, SL Marbán, H Redelt, BC … - Obesity research, 2004 - sochob.cl
Abstract ROTH, JESSE, XIAOLING QIANG, SHARON LEE MARA´ N, HENRY REDELT, AND
BARBARA C. LOWELL. The obesity pandemic: where have we been and where are we
going? Obes Res. 2004;12:88S–101S. Obesity, a new pandemic, is associated ...
Cited by 70 - Related articles - View as HTML - All 6 versions

Dispelling myths and removing barriers about insulin in type 2 diabetes


J Meece - The Diabetes Educator, 2006 - tde.sagepub.com
The burden that diabetes has placed on the health care system as a result of
increased morbidity, mortality, and economic costs has continued to increase
with each new decade. A review of data from the Third National Health and ...
Cited by 57 - Related articles - All 3 versions

Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones


CJ Bailey - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 50 - Related articles - BL Direct - All 5 versions

ACE/AACE consensus conference on the implementation of outpatient management of …


HE Lebovitz, MM Austin, L Blonde, JA … - Endocrine Practice, 2006 - AACE
Among the more than 20 million Americans who have diabetes, approximately 30% of
the cases are undi- agnosed (1). An additional 42 million people in the United
States have pre-diabetes (impaired glucose tolerance [IGT], impaired ...
Cited by 34 - Related articles - All 2 versions

The effect of rosiglitazone on overweight subjects with type 1 diabetes


SM Strowig, P Raskin - Diabetes Care, 2005 - Am Diabetes Assoc
RESULTS—Both groups experienced a significant reduction in HbA 1c (A1C) level
(rosiglitazone: 7.9 ± 1.3 to 6.9 ± 0.7%, P < 0.0001; placebo: 7.7 ± 0.8 to
7.0 ± 0.9%, P = 0.002) and a significant increase in weight ...
Cited by 26 - Related articles - BL Direct - All 6 versions

Adding Insulin Glargine Versus Rosiglitazone


AI Vinik, Q Zhang - Diabetes Care, 2007 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—HRQOL was evaluated in 217 subjects uncontrolled
with sulfonylurea plus metformin, enrolled in a 24-week, multicenter,
randomized, open-label, parallel-group trial of add-on insulin glargine ...
Cited by 25 - Related articles - BL Direct - All 7 versions

Medications associated with weight gain


M Malone - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books
STUDY SELECTION AND DATA EXTRACTION : Changes in weight are generally reported
as a primary or secondary outcome of many studies. Where possible, prospective,
randomized, controlled trials were preferred; however, many studies were ...
Cited by 23 - Related articles - BL Direct - All 6 versions

Making the transition from oral to insulin therapy


MC Riddle - The American journal of medicine, 2005 - Elsevier
The typically long delay in starting insulin for patients with type 2 diabetes
mellitus may be due in part to uncertainty about how best to make the transition
from oral therapy to insulin. Recent studies show that when appropriate ...
Cited by 22 - Related articles - All 7 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google